4//SEC Filing
Klichinsky Michael 4
Accession 0001104659-25-007571
CIK 0001485003other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:02 PM ET
Size
5.7 KB
Accession
0001104659-25-007571
Insider Transaction Report
Form 4
Klichinsky Michael
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-28+221,000→ 221,000 totalExercise: $0.50Exp: 2035-01-28→ Common Stock (221,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.
Documents
Issuer
Carisma Therapeutics Inc.
CIK 0001485003
Entity typeother
Related Parties
1- filerCIK 0001967221
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:02 PM ET
- Size
- 5.7 KB